Drug intelligence / Profile preview

2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:** 2',3'-Dideoxy‑3'‑fluoro‑uridine‑5'‑diphosphate (FUDP) is a synthetic nucleoside diphosphate analog of uridine. It is characterized by the absence of hydroxyl groups at the 2' and 3' positions and a fluorine substitution at the 3' position on the ribose ring. This compound belongs to the class of organic pyrophosphates and nucleoside analogs[1][4]. As an experimental small molecule with no current clinical approval or known therapeutic indication[3], it is primarily used in biochemical research as a substrate or inhibitor in studies involving nucleotide metabolism and polymerase activity. Its mechanism of action likely involves interference with nucleic acid synthesis due to its structural similarity to natural uridine diphosphates.

Other names
2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate(((((2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-fluorooxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)phosphonic acid[({[(2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-fluorooxolan‑2‑yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid
02

Targets

TYMP (Thymidine phosphorylase)TS (Thymidylate synthase)

Beyond the preview

Go deeper on 2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call